Interaction of an atypical Plasmodium falciparum ETRAMP with human apolipoproteins

Department of Genome Sciences, University of Washington, Box 355065, Seattle, WA 98195, USA.
Malaria Journal (Impact Factor: 3.49). 11/2008; 7:211. DOI: 10.1186/1475-2875-7-211
Source: PubMed

ABSTRACT In order to establish a successful infection in the human host, the malaria parasite Plasmodium falciparum must establish interactions with a variety of human proteins on the surface of different cell types, as well as with proteins inside the host cells. To better understand this aspect of malaria pathogenesis, a study was conducted with the goal of identifying interactions between proteins of the parasite and those of its human host.
A modified yeast two-hybrid methodology that preferentially selects protein fragments that can be expressed in yeast was used to conduct high-throughput screens with P. falciparum protein fragments against human liver and cerebellum libraries. The resulting dataset was analyzed to exclude interactions that are not likely to occur in the human host during infection.
An initial set of 2,200 interactions was curated to remove proteins that are unlikely to play a role in pathogenesis based on their annotation or localization, and proteins that behave promiscuously in the two-hybrid assay, resulting in a final dataset of 456 interactions. A cluster that implicates binding between P. falciparum PFE1590w/ETRAMP5, a putative parasitophorous vacuole membrane protein, and human apolipoproteins ApoA, ApoB and ApoE was selected for further analysis. Different isoforms of ApoE, which are associated with different outcomes of malaria infection, were shown to display differential interactions with PFE1590w.
A dataset of interactions between proteins of P. falciparum and those of its human host was generated. The preferential interaction of the P. falciparum PFE1590w protein with the human ApoE epsilon3 and ApoE epsilon4 isoforms, but not the ApoE epsilon2 isoform, supports the hypothesis that ApoE genotype affects risk of malaria infection. The dataset contains other interactions of potential relevance to disease that may identify possible vaccine candidates and drug targets.

Download full-text


Available from: Sudhir Sahasrabudhe, Jul 08, 2015
  • Source
    • "The life cycle of this parasite in the human host includes the developmental cycle in the red blood cells (RBC), and then the transformation cycle in the liver cell parenchyma. P. falciparum has been found to establish successful infection in human host by interacting with a variety of human proteins on the surface of the different cell types, as well as those in the cells of the host [3] [4] . Other biochemical events that have been reported to occur in malaria include cellular changes in energy metabolism, hemo metabolism, membrane lipid peroxidation (LPO) and stress enzymes [5] . "
    [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the relationship between malaria parasite status and cholesterol level of 110 consenting subjects (55 patients and 55 controls) in parts of the Imo River Basin of Nigeria. Giemsa staining was used for malaria parasite examination while Randox cholesterol kit was used for cholesterol level estimation. About 49 persons (90%) with malaria had low cholesterol (<180 mg/dL). Highest mean cholesterol levels were 274 mg/dL for study patients and 220 mg/dL for controls respectively; Lowest mean cholesterol levels were 168 mg/dL (patients) and 138 mg/dL (controls) respectively. Low cholesterol levels (<180 mg/dL) were found in patients (84%) and controls (6%) respectively. However, 16.4% of controls and 6% of patients had borderline cholesterol level (200-239 mg/dL). This study establishes a significant correlation (12.9%, P<0.01) between malaria parasite status and cholesterol level. These findings imply that cholesterol level estimation may be a potential concurrent and valuable diagnosis for malaria status.
    Asian Pacific Journal of Tropical Medicine 12/2011; 4(12):993-6. DOI:10.1016/S1995-7645(11)60232-0 · 0.93 Impact Factor
  • Source
    • "The next important experiments to characterize this family will be the identification of host factors that they bind directly at the PVM. To date, three studies have described binding between ETRAMPs and host proteins (Mikolajczak et al., 2007, Vignali et al., 2008, Garcia et al., 2009). Vignali et al. observed an interaction between P. falciparum ETRAMP5 and human apolipoproteins in a yeast two-hybrid system, and Garcia et al. found specific binding between synthetic peptides representing parts of ETRAMP10.2 "
    [Show abstract] [Hide abstract]
    ABSTRACT: The early transcribed membrane proteins (ETRAMPs) are a family of small, highly charged transmembrane proteins unique to malaria parasites. Some members of the ETRAMP family have been localized to the parasitophorous vacuole membrane that separates the intracellular parasite from the host cell and thus presumably have a role in host-parasite interactions. Although it was previously shown that two ETRAMPs are critical for rodent malaria parasite liver-stage development, the importance of most ETRAMPs during the parasite life cycle remains unknown. Here, we comprehensively identify nine new etramps in the genome of the rodent malaria parasite Plasmodium yoelii, and elucidate their conservation in other malaria parasites. etramp expression profiles are diverse throughout the parasite life cycle as measured by RT-PCR. Epitope tagging of two ETRAMPs demonstrates protein expression in blood and liver stages, and reveals differences in both their timing of expression and their subcellular localization. Gene targeting studies of each of the nine uncharacterized etramps show that two are refractory to deletion and thus likely essential for blood-stage replication. Seven etramps are not essential for any life cycle stage. Systematic characterization of the members of the ETRAMP family reveals the diversity in importance of each family member at the interface between host and parasite throughout the developmental cycle of the malaria parasite.
    Cellular Microbiology 08/2011; 13(11):1755-67. DOI:10.1111/j.1462-5822.2011.01656.x · 4.82 Impact Factor
  • Source
    • "About 500 million cases of malaria occur every year, and one million people, mostly children living in sub-Saharan Africa, die as a result. The malaria parasite Plasmodium falciparum was found to establish a successful infection in the human host by interacting with a variety of human proteins on the surface of different cells types, as well as with proteins inside the host cells (Vignali et al., 2008; Tuterja, 2007). The World Health Organization has revived its earlier programs on malaria eradication, which lead to a non-significant outcome (Tuterja, 2007; WHO, 2006; WHO/PAHO, 2006; WHO/Regional Office for Europe, 2006; WHO/Regional Office for the Eastern Mediterranean, 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The current study is a hospital based investigation, in which attempts were being made to establish the effect of falciparum malarial infection on cholesterol level and platelet counts. The level of parasitaemia and its correlation with cholesterol level and platelet count in malaria patients was investigated. Two hundred clinically diagnosed malaria patients and 200 age matched healthy blood donors were included in the current study. In each case, blood sample was analyzed for serum cholesterol level and platelet count to establish a correlation between such parameters with paraesitemia. Based on the results obtained, it was evident that there was a highly significant reduction in the serum cholesterol level and the platelet count in malaria patients having high levels of parasitaemia. The low levels of cholesterol and platelets in malaria patients provided basis for the possible use of such clinical data in the diagnosis of malaria in the absence of a positive blood film.
    Journal of Saudi Chemical Society 01/2010; 14(1-14):83-89. DOI:10.1016/j.jscs.2009.12.013 · 1.29 Impact Factor